)
Lyell Immunopharma (LYEL) investor relations material
Lyell Immunopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 10, 2026, with voting available online or virtually until June 9, 2026.
Shareholders are encouraged to review proxy materials and vote on key proposals affecting governance and compensation.
Voting matters and shareholder proposals
Election of three Class II directors: Richard Klausner, M.D., Otis Brawley, M.D., and William Rieflin, all recommended by the board.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers.
Proxies may vote on other business arising at the meeting or any adjournments.
Board of directors and corporate governance
Board recommends all three director nominees for election to Class II positions.
- Director elections, auditor ratification, and executive pay up for vote at virtual annual meeting.LYEL
Proxy filing24 Apr 2026 - Ronde-cel leads next-gen CAR T-cell therapy with strong efficacy, safety, and first-mover advantage.LYEL
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Registration enables resale of 1,952,360 shares from a prior private placement, no proceeds raised.LYEL
Registration filing3 Apr 2026 - Pivotal CAR T-cell trials advance with strong efficacy, robust cash runway, and key milestones ahead.LYEL
Q4 202512 Mar 2026 - Pivotal CAR T-cell trials show strong efficacy, with key data updates and solid funding ahead.LYEL
The Citizens Life Sciences Conference 202610 Mar 2026 - Strong clinical progress and financing support pivotal CAR T-cell trials and novel solid tumor programs.LYEL
Leerink Global Healthcare Conference 20269 Mar 2026 - Pivotal CAR T-cell trials advance in lymphoma and colorectal cancer, with strong early results.LYEL
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - High response rates in LBCL and mCRC with next-gen CAR T therapies and pivotal trials ongoing.LYEL
Company presentation2 Mar 2026 - 40% response and 60% benefit rates achieved at high dose, with manageable safety and tumor infiltration.LYEL
Study Update3 Feb 2026
Next Lyell Immunopharma earnings date
Next Lyell Immunopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)